1. Home
  2. WBX vs IVVD Comparison

WBX vs IVVD Comparison

Compare WBX & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • IVVD
  • Stock Information
  • Founded
  • WBX 2015
  • IVVD 2020
  • Country
  • WBX Spain
  • IVVD United States
  • Employees
  • WBX N/A
  • IVVD N/A
  • Industry
  • WBX Industrial Specialties
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • WBX Consumer Discretionary
  • IVVD Health Care
  • Exchange
  • WBX Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • WBX 85.1M
  • IVVD 69.0M
  • IPO Year
  • WBX N/A
  • IVVD 2021
  • Fundamental
  • Price
  • WBX $5.93
  • IVVD $0.74
  • Analyst Decision
  • WBX Buy
  • IVVD Strong Buy
  • Analyst Count
  • WBX 3
  • IVVD 3
  • Target Price
  • WBX $14.33
  • IVVD $5.85
  • AVG Volume (30 Days)
  • WBX 18.7K
  • IVVD 1.2M
  • Earning Date
  • WBX 07-31-2025
  • IVVD 08-13-2025
  • Dividend Yield
  • WBX N/A
  • IVVD N/A
  • EPS Growth
  • WBX N/A
  • IVVD N/A
  • EPS
  • WBX N/A
  • IVVD N/A
  • Revenue
  • WBX $171,352,140.00
  • IVVD $36,688,000.00
  • Revenue This Year
  • WBX N/A
  • IVVD $345.16
  • Revenue Next Year
  • WBX $44.10
  • IVVD $161.08
  • P/E Ratio
  • WBX N/A
  • IVVD N/A
  • Revenue Growth
  • WBX 3.75
  • IVVD N/A
  • 52 Week Low
  • WBX $4.60
  • IVVD $0.35
  • 52 Week High
  • WBX $32.80
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • WBX 83.14
  • IVVD 46.84
  • Support Level
  • WBX $5.92
  • IVVD $0.66
  • Resistance Level
  • WBX $6.25
  • IVVD $0.76
  • Average True Range (ATR)
  • WBX 0.26
  • IVVD 0.04
  • MACD
  • WBX 0.20
  • IVVD 0.00
  • Stochastic Oscillator
  • WBX 91.95
  • IVVD 55.51

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: